J.P. Morgan is targeting tech startups as clients after Silicon Valley Bank, First Republic Bank and Silvergate Bank ...

Fintel reports that on November 14, 2024, JP Morgan initiated coverage of Blueprint Medicines (NasdaqGS:BPMC) with a ...

With 2025 on the horizon, investors are sharpening their focus on the year ahead, selecting portfolio additions that aim to bring solid ...

J.P. Morgan Chase is focused on supporting the growth of companies along the Front Range of the Rockies by advising on ...

JP Morgan initiated coverage on Blueprint Medicines Corporation (NASDAQ:BPMC), a biotech company focused on modulating immune ...

In a report released today, Andrew Wilson CFA from J.P. Morgan maintained a Buy rating on Siemens (0P6M – Research Report), with a price ...

JPMorgan is assessing options for its European headquarters in London as the fast-expanding Wall Street bank outgrows its ...

(NASDAQ:BLUE) traded lower for the fourth straight session as Bank of America and J.P. Morgan downgraded the gene therapy developer after its Q3 2024 results fell short of expectations for ...

JPMorgan CEO Jamie Dimon said Wall Street is buzzing at the prospect of Trump deregulating the banking industry and making it ...

The longtime chief executive – who assumed the role in 2006 – criticized years of stringent regulations on the banking sector ...

JPMorgan Chase and Bank of America stocks rallied post-election, both outperforming their sector. Click here to read an ...

Investor preferences seem to have shifted from gold to equities amid confidence in the President-elect's economic policies.